WHY AI ISN’T ALWAYS THE ANSWER FOR MODERN PHARMACY


By Nicholas Batten, Co-founder and CTO at Nuumad


As pressures on the NHS continue to grow, pharmacies are expanding beyond dispensing into clinical, patient facing roles, from prescribing services to preventative care and long term condition management.


Technology is often presented as the answer to making this shift scalable with much of that conversation currently centred on artificial intelligence (AI). But despite the excitement, a study published (interface-design.co.uk) says AI is not always the fastest, safest or most appropriate solution for pharmacy and clinic environments. In highly regulated healthcare settings, smarter system design, not more AI, will determine whether digital transformation succeeds.


AI in pharmacy: promise versus reality


Used carefully, AI can reduce administrative burden and help clinicians process information more efficiently. However, the assumption that AI automatically speeds up workflows or replaces existing processes is often misplaced.


Unlike traditional software, many AI systems are probabilistic. They generate responses based on patterns not fixed rules, meaning outputs can vary even when given the same input. In consumer applications this flexibility is useful. In clinical environments, it introduces risk.


Pharmacy consultations require consistency, traceability and clear accountability. Every decision must be explained, auditable and aligned with clinical protocols. When human oversight is required to verify AI outputs the promised efficiency gains can quickly diminish. In practice, pharmacists become supervisors of technology and this changes workflows rather than simplifying them.


The regulation gap


A further challenge is regulation has not yet fully caught up with AI innovation. UK healthcare regulators, including the Medicines and Healthcare products Regulatory Agency (MHRA), are actively developing frameworks for AI driven medical technologies. But standards are still evolving, leaving pharmacy operators navigating uncertainty around compliance, liability and governance.


30 pharmacyinfocus.co.uk


For pharmacy teams already working within strict professional and legal obligations, adopting tools that cannot clearly demonstrate how decisions are made presents a real concern. Until regulatory clarity matures, human oversight remains essential and that means AI alone cannot be treated as an autonomous solution.


When simpler technology works better


Many operational challenges in pharmacy like eligibility checks, protocol adherence and structured consultations, benefit more from deterministic systems built on predefined clinical logic.


These systems follow transparent rules. Every pathway is reproducible and auditable, which aligns naturally with regulatory expectations. Rather than generating possibilities, they enforce consistency. For pharmacists, this translates into confidence. Processes become standardised, training becomes easier and consultations follow clear clinical frameworks without removing professional judgement.


This does not mean AI has no role. Instead, its value often sits at the edges of workflows rather than at their core. AI may help organise patient inputs or highlight relevant information, while rule based systems ensure clinical decisions remain compliant and predictable. The most effective digital environments combine both approaches, using AI to enhance usability while relying on structured systems to safeguard patient care.


Designing systems around pharmacists, not technology


Modern consultation platforms are increasingly acting as co-ordination layers, guiding interactions from initial symptom capture through to treatment decisions and follow-up care. When designed well, these systems reduce fragmentation between tools and minimise manual administration. Instead of switching between disconnected platforms, pharmacists work within a single structured workflow where patient data, clinical protocols and documentation are integrated.


The impact is practical rather than theoretical. Consultations become more consistent, onboarding new staff becomes faster and services can scale without proportionally increasing operational complexity or risk. This approach supports expansion into private services such as travel health, weight management and preventative care without adding unsustainable administrative pressure.


At the heart of this model is structured data. Capturing patient information in consistent, machine readable formats enables automation, reporting and continuous improvement while maintaining compliance and audit readiness.


Innovation requires restraint


Pharmacy leaders must balance innovation with patient safety, professional accountability and regulatory responsibility. Deploying AI simply because it is available can introduce unnecessary complexity and risk. The question to ask is “What problem are we trying to solve?”. Sometimes the answer will involve AI. Often, it will involve better workflows, clearer governance and systems designed specifically for clinical environments rather than adapted from consumer technology.


Pharmacies are becoming decentralised healthcare providers. Technology will play a crucial role in enabling this shift but success will depend on trust as much as innovation. AI will undoubtedly become part of the pharmacy toolkit. Yet for now, human expertise, transparent systems and well designed workflows remain the foundation of safe and scalable care. The future of pharmacy will not be defined by how quickly AI is adopted, but by how intelligently technology is implemented.


“AI is not always the fastest, safest or most appropriate solution for pharmacy and clinic environments...


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48